Literature DB >> 7531851

Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats.

L Robson1, A J Gower, D A Kendall, C A Marsden.   

Abstract

Mature (3-4 months) and aged (18-19 months) Sprague-Dawley (SD) rats were treated with 5-HT receptor agonists and drug-induced behaviours monitored. The 5-HT2/1C agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), induced wet dog shakes and back muscle contractions which were significantly increased in aged, compared to mature, rats, suggesting an age-related enhancement of 5-HT2 receptor function. In contrast, the selective 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) induced forepaw treading, flat body posture, hypothermia and hyperactivity which were not significantly different in aged compared to mature rats. Levels of 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) in the hippocampus and frontal cortex were measured using high performance liquid chromatography with electrochemical detection. There were no age-related changes in hippocampal 5-HT or 5-HIAA. However both 5-HT and 5-HIAA were increased in the frontal cortex of aged SD rats. 8-OH-DPAT reduced 5-HIAA in both regions examined in mature rats, an effect which was attenuated in the aged rats, suggesting an age-related reduction in presynaptic 5-HT1A receptor function. DOI did not induce any changes in 5-HT or 5-HIAA in either of the regions examined. Radioligand binding studies with [3H] ketanserin showed there to be no significant age-related changes in cortical 5-HT2 receptor density or affinity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7531851     DOI: 10.1007/bf02245710

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

1.  Age-Related Changes in 5-Ht Mediated Effects in Vivo in the Rat: Gower AJ, Gobert J. UCB Pharma, Chemin du Foriest, 1420 Braine l'Alleud, Belgium.

Authors: 
Journal:  J Psychopharmacol       Date:  1992-01       Impact factor: 4.153

Review 2.  What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia.

Authors:  H J Altman; H J Normile
Journal:  Neurobiol Aging       Date:  1988 Sep-Dec       Impact factor: 4.673

3.  Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment.

Authors:  N Brunello; M Riva; A C Rovescalli; R Galimberti; G Racagni
Journal:  Pharmacol Toxicol       Date:  1988-09

Review 4.  Serotonin and anxiety revisited.

Authors:  R S Kahn; H M van Praag; S Wetzler; G M Asnis; G Barr
Journal:  Biol Psychiatry       Date:  1988-01-15       Impact factor: 13.382

5.  In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism.

Authors:  F Crespi; J C Garratt; A J Sleight; C A Marsden
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

6.  5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders.

Authors:  J O Marcusson; I Alafuzoff; I T Bäckström; E Ericson; C G Gottfries; B Winblad
Journal:  Brain Res       Date:  1987-11-03       Impact factor: 3.252

7.  Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain.

Authors:  D N Middlemiss; A M Palmer; N Edel; D M Bowen
Journal:  J Neurochem       Date:  1986-03       Impact factor: 5.372

8.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

9.  Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.

Authors:  T Sharp; L I Backus; S Hjorth; S R Bramwell; D G Grahame-Smith
Journal:  Eur J Pharmacol       Date:  1990-02-13       Impact factor: 4.432

10.  Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.

Authors:  A M Palmer; P T Francis; J S Benton; N R Sims; D M Mann; D Neary; J S Snowden; D M Bowen
Journal:  J Neurochem       Date:  1987-01       Impact factor: 5.372

View more
  1 in total

1.  Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects.

Authors:  Y Gelfin; B Lerer; K P Lesch; M Gorfine; B Allolio
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.